About mustine hydrochloride
Alkylating chemotherapy medicine
Used for
- Treatment of Hodgkin lymphoma and other lymphomas
- Treatment of chronic lymphocytic leukaemia
- Sometimes used for other cancers under specialist care
Usual adult dose
Specialist-administered intravenous dose is based on body surface area and treatment plan; schedules vary by cancer.
Usual dose in children
Specialist dosing is based on body surface area and treatment plan; schedules vary by cancer.
Common side effects
- Nausea and vomiting
- Low blood-cell counts, increasing infection or bleeding risk
- Hair loss
- Sore mouth or throat
Important warnings
- Given by trained clinicians; leakage outside the vein can cause serious tissue damage.
- Can severely suppress bone marrow and increase infection or bleeding risk.
- Requires blood-count monitoring; treatment may need to be delayed for low counts.
- May harm fertility and can increase the risk of later cancers.
Pregnancy
Can cause fetal harm. Pregnancy should be avoided during treatment; specialist guidance is essential.
Breastfeeding
Breastfeeding is not recommended during treatment because of potential serious harm to the infant.
Interactions
- Other medicines that suppress bone marrow can increase blood-cell problems.
- Live vaccines may cause infection during chemotherapy-induced immune suppression.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.